Sign inJoin waitlistJoin the waitlist

Beverly Moy

Clinical Director of the Breast Oncology Program at Massachusetts General Hospital · Harvard School of Public Health

Credentials: · · ·

History

Breast Oncology Program at Massachusetts General Hospital · Harvard School of Public Health
Present

Medical Oncology
1999–2001
Internal Medicine
1996–1999
Harvard School of Public Health
Albert Einstein College of Medicine
1992–1996
Johns Hopkins University
1988–1992

Research

Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer
New England Journal of Medicine · 2015 · 577 citations
Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in HER2-Positive Metastatic Breast Cancer Previously Treated With ≥ 2 HER2-Directed Regimens: Phase III NALA Trial
Journal of Clinical Oncology · 2020 · 486 citations
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Oncology · 2017 · 456 citations

Aditya Bardia
39 papers
LS
Laura Spring
37 papers · 4 as a fellow
SI
Steven Isakoff
31 papers
LE
Leif Ellisen
23 papers
Eric Winer
22 papers
Nancy Lin
17 papers
Ann Partridge
16 papers
AW
Antonio Wolff
16 papers
Hope Rugo
16 papers
SW
Seth Wander
16 papers · 4 as a fellow
Jeffrey Peppercorn
15 papers
DJ
Dejan Juric
14 papers